FDA approval: Uridine triacetate for the treatment of patients following fluorouracil or capecitabine overdose or exhibiting early-onset severe toxicities following administration of these drugs

Gwynn Ison, Julia A. Beaver, W. David McGuinn, Todd R. Palmby, Jeannette Dinin, Rosane Charlab, Anshu Marathe, Runyan Jin, Qi Liu, Xiao Hong Chen, Xavier Ysern, Olen Stephens, Ge Bai, Yaning Wang, Sarah E. Dorff, Joyce Cheng, Shenghui Tang, Rajeshwari Sridhara, William Pierce, Amy E. McKeeAmna Ibrahim, Geoffrey Kim, Richard Pazdur

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'FDA approval: Uridine triacetate for the treatment of patients following fluorouracil or capecitabine overdose or exhibiting early-onset severe toxicities following administration of these drugs'. Together they form a unique fingerprint.

Medicine & Life Sciences